Pacira BioSciences Inc (PCRX)
16.57
-0.03
(-0.18%)
USD |
NASDAQ |
Nov 01, 16:00
16.55
-0.02
(-0.12%)
After-Hours: 20:00
Pacira BioSciences Gross Profit Margin (Quarterly): 75.14% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 75.14% |
| March 31, 2024 | 71.63% |
| December 31, 2023 | 73.69% |
| September 30, 2023 | 75.75% |
| June 30, 2023 | 71.55% |
| March 31, 2023 | 69.43% |
| December 31, 2022 | 63.99% |
| September 30, 2022 | 69.74% |
| June 30, 2022 | 70.12% |
| March 31, 2022 | 77.17% |
| December 31, 2021 | 75.50% |
| September 30, 2021 | 72.87% |
| June 30, 2021 | 74.00% |
| March 31, 2021 | 73.66% |
| December 31, 2020 | 73.05% |
| September 30, 2020 | 74.47% |
| June 30, 2020 | 70.46% |
| March 31, 2020 | 71.87% |
| December 31, 2019 | 73.94% |
| September 30, 2019 | 78.69% |
| June 30, 2019 | 75.44% |
| March 31, 2019 | 70.10% |
| December 31, 2018 | 74.79% |
| September 30, 2018 | 77.15% |
| June 30, 2018 | 75.13% |
| Date | Value |
|---|---|
| March 31, 2018 | 69.33% |
| December 31, 2017 | 73.07% |
| September 30, 2017 | 72.93% |
| June 30, 2017 | 66.43% |
| March 31, 2017 | 64.52% |
| December 31, 2016 | 67.60% |
| September 30, 2016 | 36.87% |
| June 30, 2016 | 66.90% |
| March 31, 2016 | 69.03% |
| December 31, 2015 | 71.97% |
| September 30, 2015 | 74.44% |
| June 30, 2015 | 68.00% |
| March 31, 2015 | 69.85% |
| December 31, 2014 | 69.30% |
| September 30, 2014 | 60.82% |
| June 30, 2014 | 57.69% |
| March 31, 2014 | 50.56% |
| December 31, 2013 | 45.25% |
| September 30, 2013 | 36.41% |
| June 30, 2013 | 40.41% |
| March 31, 2013 | 1.69% |
| December 31, 2012 | 7.44% |
| September 30, 2012 | -9.44% |
| June 30, 2012 | 45.84% |
| March 31, 2012 | 16.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
63.99%
Minimum
Dec 2022
77.17%
Maximum
Mar 2022
72.53%
Average
73.05%
Median
Dec 2020
Gross Profit Margin (Quarterly) Benchmarks
| Cyclo Therapeutics Inc | 89.13% |
| Revance Therapeutics Inc | 73.03% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.43% |
| Return on Assets | 4.03% |
| Return on Invested Capital | 4.55% |
| Profit Margin (Quarterly) | 10.61% |
| Operating Margin (Quarterly) | 17.40% |
| Return on Net Operating Assets | 5.88% |